Renaissance Technologies’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-11,102
Closed -$56K 4105
2024
Q1
$56K Sell
11,102
-372
-3% -$1.88K ﹤0.01% 3469
2023
Q4
$77K Buy
+11,474
New +$77K ﹤0.01% 3369
2023
Q3
Sell
-2,390
Closed -$50K 4236
2023
Q2
$50K Sell
2,390
-13,199
-85% -$276K ﹤0.01% 3618
2023
Q1
$419K Buy
15,589
+5,346
+52% +$144K ﹤0.01% 2971
2022
Q4
$363K Buy
+10,243
New +$363K ﹤0.01% 3133
2021
Q4
Sell
-4,429
Closed -$888K 4309
2021
Q3
$888K Buy
4,429
+3,308
+295% +$663K ﹤0.01% 2613
2021
Q2
$286K Sell
1,121
-2,442
-69% -$623K ﹤0.01% 3161
2021
Q1
$946K Buy
+3,563
New +$946K ﹤0.01% 2634
2020
Q2
Sell
-9,039
Closed -$1.84M 3840
2020
Q1
$1.84M Buy
9,039
+4,268
+89% +$871K ﹤0.01% 2092
2019
Q4
$2.13M Sell
4,771
-1,940
-29% -$867K ﹤0.01% 2295
2019
Q3
$2.06M Sell
6,711
-3,243
-33% -$997K ﹤0.01% 2266
2019
Q2
$3.17M Buy
9,954
+656
+7% +$209K ﹤0.01% 2093
2019
Q1
$3.9M Buy
9,298
+860
+10% +$361K ﹤0.01% 1965
2018
Q4
$2.57M Sell
8,438
-856
-9% -$261K ﹤0.01% 2092
2018
Q3
$3.35M Buy
9,294
+1,620
+21% +$583K ﹤0.01% 2030
2018
Q2
$2.81M Buy
7,674
+2,206
+40% +$807K ﹤0.01% 2099
2018
Q1
$1.62M Buy
5,468
+2,234
+69% +$660K ﹤0.01% 2445
2017
Q4
$1.35M Buy
3,234
+600
+23% +$251K ﹤0.01% 2539
2017
Q3
$869K Buy
2,634
+1,853
+237% +$611K ﹤0.01% 2619
2017
Q2
$185K Buy
+781
New +$185K ﹤0.01% 3007
2015
Q2
Sell
-663
Closed -$5.65M 3426
2015
Q1
$5.65M Buy
663
+615
+1,281% +$5.24M 0.01% 1282
2014
Q4
$422K Buy
+48
New +$422K ﹤0.01% 2484